AIDS‐associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre‐ and post‐HAART eras. Experience of a single centre in Italy
Open Access
- 16 December 2008
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 10 (1) , 6-11
- https://doi.org/10.1111/j.1468-1293.2008.00645.x
Abstract
Objectives To assess the prevalence, clinical and immunological characteristics, risk factors and survival of patients with AIDS-related cryptococcosis in the era of highly active antiretroviral therapy (HAART). Methods All newly diagnosed cryptococcosis cases identified retrospectively from among a series of AIDS patients hospitalized consecutively at a single institution in Italy in 1985-1996 (pre-HAART period, n=165) and 1997-2006 (post-HAART period, n=40) were analysed comparatively. Results The prevalence of cryptococcosis decreased from 4.7% (165/3543) to 2.2% (40/1805) between the pre- and post-HAART periods (P=0.0001). There were no differences in the clinical features or immunological status of the patients between the two cohorts. The variables associated with the occurrence of cryptococcosis in the post-HAART era were older age (P<0.001), no previous diagnosis of HIV infection (P<0.001) and infection in homosexual males (P=0.004). During the post-HAART period, immune reconstitution inflammatory syndrome associated with cryptococcosis was observed in five patients (19.3%) a median of 15 weeks after the start of HAART. Thirty-day survival (P=0.045) and overall survival (P=0.0001) were significantly better among patients diagnosed with cryptococcosis in the post-HAART compared to those diagnosed in the pre-HAART era. Conclusions The AIDS-associated cryptococcosis observed in Western countries in the HAART era has similar clinical and immunological characteristics to that observed in the pre-HAART era, but a significantly better outcome.Keywords
This publication has 21 references indexed in Scilit:
- Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D StudyPLoS Medicine, 2007
- Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalenceAIDS, 2006
- Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapyAIDS, 2006
- Discontinuation of Maintenance Therapy for Cryptococcal Meningitis in Patients with AIDS Treated with Highly Active Antiretroviral Therapy: An International Observational StudyClinical Infectious Diseases, 2004
- Epidemiology of HIV-associated cryptococcosis in France (1985–2001)AIDS, 2004
- Declining Incidence of AIDS and Increasing Prevalence of AIDS Presenters Among AIDS Patients in ItalyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Immune Reconstitution Cryptococcosis after Initiation of Successful Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2002
- A Pilot Study of the Discontinuation of Antifungal Therapy for Disseminated Cryptococcal Disease in Patients with Acquired Immunodeficiency Syndrome, following Immunologic Response to Antiretroviral TherapyThe Journal of Infectious Diseases, 2002
- HIV Infection Among Foreign Transsexual Sex Workers in RomeSexually Transmitted Diseases, 2001
- Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapyAIDS, 2000